| Literature DB >> 25875335 |
Jie Yin1, Mingfeng Liu2, Wenkai Ren1, Jielin Duan1, Guan Yang3, Yurong Zhao2, Rejun Fang2, Lixiang Chen2, Tiejun Li4, Yulong Yin5.
Abstract
This study aimed to investigate the protective effects of dietary glutamate and aspartate supplementations on diquat-induced oxidative stress in piglets. Diquat injection significantly reduced growth performance, including body weight, average daily weight gain, and feed intake (P<0.05). Meanwhile, diquat administration induced oxidative stress evidenced by the decreased serum nitric oxide (NO) and elevated malondialdeyhde (MDA) concentration (P<0.05). Furthermore, diquat-induced oxidative stress disrupted intestinal absorption system and decreased serum threonine, serine, and glycine levels. Dietary supplementation with glutamate improved final body weight, antioxidant system, and expressions of amino acids transporters and enhanced serum glutamate concentration compared with diquat group (P<0.05). While aspartate failed to alleviate diquat-induced oxidative stress, growth depression, and dysfunction of nutrients absorption except for liver relative weight. In conclusion, dietary supplementation with glutamate confers beneficial effects on diquat-induced oxidative stress in piglets, while aspartate exhibits little effects.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25875335 PMCID: PMC4398417 DOI: 10.1371/journal.pone.0122893
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers used in this study.
| Gene | Accession No. | Primer squence (5’-3’) | Size (bp) |
|---|---|---|---|
| SLC1A1 | NM_001164649.1 | F:GGCACCGCACTCTACGAAGCA | 177 |
| R:GCCCACGGCACTTAGCACGA | |||
| SLC7A1 | NM_001012613.1 | F: TGCCCATACTTCCCGTCC | 192 |
| R:GGTCCAGGTTACCGTCAG | |||
| NAAT | XM_003355984.2 | F:GATTGTGGAGATGGAGGATGTG | 128 |
| R:TGCGAGTGAAGAGGAAGTAGAT | |||
| β-actin | XM_003124280.3 | F:CTGCGGCATCCACGAAACT | 147 |
| R:AGGGCCGTGATCTCCTTCTG |
F: forward primer; R: reverse primer; SLC1A1: solute carrier family 1, member 1; SLC7A1: solute carrier family 7, member 1; NAAT: neutral amino acid transporter.
Growth performance and relative organ weights in four groups.
| Item | Control | Diquat | Glutamate | Aspartate | SE | p-value |
|---|---|---|---|---|---|---|
| Initial body weight (kg) | 9.88±0.70 | 9.90±0.61 | 9.98±0.65 | 9.91±0.59 | 0.30 | 0.999 |
| Final body weight (kg) | 11.36±0.62 | 8.87±0.75 | 10.31±0.50 | 8.82±0.47 | 0.44 | 0.009 |
| Average daily weight gain (kg) | 0.32±0.05 | -0.08±0.04 | -0.06±0.01 | -0.12±0.04 | 0.05 | <0.001 |
| Average daily intake (kg) | 0.61±0.07 | 0.26±0.07 | 0.32±0.03 | 0.26±0.05 | 0.04 | 0.001 |
| Heart (%) | 4.68±0.09 | 6.17±0.66 | 5.57±0.27 | 6.37±0.78 | 0.30 | 0.196 |
| Liver (%) | 26.31±0.29 | 30.80±0.84 | 31.72±1.93 | 26.27±1.66 | 0.84 | 0.017 |
| Spleen (%) | 2.02±0.05 | 1.90±0.12 | 2.05±0.09 | 2.03±0.07 | 0.04 | 0.599 |
| Kidney (%) | 5.20±0.22 | 6.44±0.58 | 6.28±0.51 | 6.10±0.37 | 0.23 | 0.225 |
a,bWithin a row, means with different superscripts differ (P<0.05). The same as below.
Fig 1Feed intake (A) and serum SOD, T-AOC, NO, and MDA levels (B, C, D, and E) in four groups after exposure to diquat.
* means feed intake in control is significantly higher than that in other three groups and # means feed intake in control is markedly higher than that in diquat and aspartate groups (P<0.05), but has no difference compared with glutamate group (P>0.05).
Fig 2Histological evaluation of intestinal tissues (HE×250) after exposure to diquat.
The intestinal villus height and crypt depth in four groups.
| Item(um) | Control | Diquat | Glutamate | Aspartate | SE | p-value |
|---|---|---|---|---|---|---|
| Jejunam | ||||||
| villus height | 385.82±21.19 | 402.55±27.18 | 357.94±10.32 | 375.56±15.60 | 10.23 | 0.507 |
| Crypt depth | 179.00±13.75 | 175.18±10.55 | 184.03±15.76 | 173.20±8.08 | 5.92 | 0.930 |
| V/C | 2.19±0.13 | 2.16±0.13 | 2.13±0.18 | 2.044±0.12 | 0.07 | 0.899 |
| Ileam | ||||||
| Villus height | 389.33±27.63 | 391.63±23.79 | 370.95±31.49 | 337.28±12.06 | 12.43 | 0.404 |
| Crypt depth | 181.20±22.18 | 185.75±21.56 | 142.56±20.57 | 147.53±10.57 | 9.84 | 0.294 |
| V/C | 2.24±0.18 | 2.03±0.18 | 2.24±0.20 | 2.21±0.08 | 0.08 | 0.806 |
Serum free amino acids in four groups.
| Item | Control | Diquat | Glutamate | Aspartate | SE | p-valve |
|---|---|---|---|---|---|---|
| Aspartate | 134.14±12.03 | 111.65±16.01 | 149.42±15.10 | 115.59±13.33 | 7.34 | 0.776 |
| Threonine | 842.33±31.23a | 490.00±95.47b | 658.88±58.44ab | 473.99±90.93b | 46.39 | 0.096 |
| Serine | 265.65±13.90a | 188.56±17.94bc | 227.00±20.31ab | 174.59±13.29c | 10.71 | 0.863 |
| Glutamate | 721.79±45.89ab | 681.63±43.59b | 872.23±74.57a | 707.58±38.32b | 28.99 | 0.118 |
| Glycine | 1548.84±74.86a | 1143.86±148.21b | 1286.86±162.39ab | 960.69±85.48b | 73.05 | 0.410 |
| Alanine | 912.77±30.54 | 937.18±92.15 | 1159.52±93.53 | 874.15±144.37 | 51.55 | 0.115 |
| Cysteine | 35.35±2.80b | 47.34±3.87ab | 57.55±4.18a | 49.26±6.41ab | 2.68 | 0.062 |
| Valine | 187.19±23.30 | 214.78±16.33 | 225.52±28.11 | 236.80±29.15 | 12.16 | 0.590 |
| Methionine | 75.57±9.37 | 51.19±7.89 | 75.89±11.61 | 50.78±2.29 | 4.74 | 0.389 |
| Isoleucine | 100.83±8.79 | 113.14±8.76 | 112.55±7.74 | 113.66±11.97 | 4.54 | 0.659 |
| Leucine | 214.20±13.01 | 244.83±10.19 | 261.60±24.51 | 231.67±15.07 | 8.54 | 0.140 |
| Tyrosine | 64.49±9.90 | 47.92±5.18 | 58.77±5.91 | 44.25±4.58 | 3.56 | 0.591 |
| Phenylalanine | 137.52±6.14 | 133.79±9.75 | 138.19±6.09 | 131.80±7.79 | 3.58 | 0.666 |
| Lysine | 472.97±56.37 | 372.02±49.98 | 399.15±55.32 | 372.37±28.24 | 24.33 | 0.499 |
| NH3 | 780.68±25.52 | 804.27±29.82 | 861.79±35.81 | 785.66±35.18 | 16.30 | 0.793 |
| Histidine | 92.60±12.51 | 83.18±6.54 | 109.84±11.89 | 101.12±8.86 | 5.20 | 0.357 |
| Arginine | 189.58±17.31 | 195.50±15.41 | 203.23±19.81 | 188.10±27.67 | 11.37 | 0.402 |
| Proline | 359.98±19.23 | 332.53±40.63 | 409.30±37.12 | 306.43±33.24 | 17.54 | 0.721 |
Fig 3Intestinal relative mRNA abundances in four groups after exposure to diquat.